BioCentury
ARTICLE | Company News

Codon Devices, Merrimack deal

April 21, 2008 7:00 AM UTC

Codon will use its BioLogic platform to engineer and optimize therapeutic proteins according to specifications designed by Merrimack. Merrimack, which is developing compounds to treat autoimmune disea...